ATE333880T1 - Montirelin zur verhinderung der schlafapnoe - Google Patents

Montirelin zur verhinderung der schlafapnoe

Info

Publication number: ATE333880T1
Authority: AT; Austria
Prior art keywords: pct; sleep apnea; montirelin; date; prevent sleep
Prior art date: 1995-10-24

Application number

AT96936996T

Other languages

English (en)

Inventor

Andrew Winokur

Allan I Pack

Original Assignee

Gruenenthal Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-10-24

Filing date

1996-10-24

Publication date

2006-08-15

1996-10-24 Application filed by Gruenenthal Gmbh filed Critical Gruenenthal Gmbh

2006-08-15 Application granted granted Critical

2006-08-15 Publication of ATE333880T1 publication Critical patent/ATE333880T1/de

Links

201000002859 sleep apnea Diseases 0.000 title abstract 2
RSHMQGIMHQPMEB-IXOXFDKPSA-N Montirelin Chemical compound N1C(=O)[C@@H](C)SC[C@H]1C(=O)N[C@H](C(=O)N1[C@@H](CCC1)C(N)=O)CC1=CN=CN1 RSHMQGIMHQPMEB-IXOXFDKPSA-N 0.000 title 1
229950004759 montirelin Drugs 0.000 title 1
108700023195 montirelin Proteins 0.000 title 1
239000002253 acid Substances 0.000 abstract 1
230000002401 inhibitory effect Effects 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/541—Non-condensed thiazines containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/05—Dipeptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Immunology (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Gastroenterology & Hepatology (AREA)
Pulmonology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Control Of Positive-Displacement Air Blowers (AREA)
Harvester Elements (AREA)

AT96936996T 1995-10-24 1996-10-24 Montirelin zur verhinderung der schlafapnoe ATE333880T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US603295P	1995-10-24	1995-10-24

Publications (1)

Publication Number	Publication Date
ATE333880T1 true ATE333880T1 (de)	2006-08-15

Family

ID=21718957

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT96936996T ATE333880T1 (de)	1995-10-24	1996-10-24	Montirelin zur verhinderung der schlafapnoe

Country Status (11)

Country	Link
US (1)	US5968932A (de)
EP (1)	EP0866711B1 (de)
JP (1)	JPH11515015A (de)
AT (1)	ATE333880T1 (de)
AU (1)	AU714270B2 (de)
CA (1)	CA2235854A1 (de)
DE (1)	DE69636393T2 (de)
DK (1)	DK0866711T3 (de)
ES (1)	ES2268712T3 (de)
PT (1)	PT866711E (de)
WO (1)	WO1997015309A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1999025356A1 (en) *	1997-11-14	1999-05-27	Akzo Nobel N.V.	Use of mirtazapine for treating sleep apneas
DE10025949A1 (de) *	2000-05-26	2001-11-29	Gruenenthal Gmbh	Arzneimittel zur Bekämpfung von Atemdepression
DE102004010516A1 (de) *	2004-03-04	2005-09-22	Bayer Technology Services Gmbh	Verbessertes Verfahren zur zeitlichen Dosierung von Arzneistoffen
US7462595B2 (en) *	2004-09-17	2008-12-09	Prange Jr Arthur Jergen	Methods for treating cancer-related fatigue
US10042980B2 (en)	2005-11-17	2018-08-07	Gearbox Llc	Providing assistance related to health
US10296720B2 (en)	2005-11-30	2019-05-21	Gearbox Llc	Computational systems and methods related to nutraceuticals
US20080114577A1 (en) *	2005-11-30	2008-05-15	Searete Llc, A Limited Liability Corporation Of The State Of Delaware	Computational methods and systems associated with nutraceutical related assays
US20080086338A1 (en) *	2006-06-23	2008-04-10	Searete Llc, A Limited Liability Corporation Of The State Of Delaware	Customized visual marking for medication labeling
US20080086339A1 (en) *	2006-06-23	2008-04-10	Searete Llc, A Limited Liability Corporation Of The State Of Delaware	Customized visual marking for medication labeling
CN111670050A (zh)	2018-01-30	2020-09-15	爱普宁公司(特拉华)	用于治疗睡眠呼吸暂停的方法和组合物
US20230135373A1 (en) *	2020-04-02	2023-05-04	Apnimed, Inc. (Delaware)	Methods and compositions for treating sleep apnea

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE408300B (sv) *	1974-10-16	1979-06-05	Gruenenthal Chemie	Sett att framstella nya dipeptidderivat

1996
- 1996-10-24 AU AU74770/96A patent/AU714270B2/en not_active Ceased
- 1996-10-24 ES ES96936996T patent/ES2268712T3/es not_active Expired - Lifetime
- 1996-10-24 CA CA002235854A patent/CA2235854A1/en not_active Abandoned
- 1996-10-24 DE DE69636393T patent/DE69636393T2/de not_active Expired - Fee Related
- 1996-10-24 EP EP96936996A patent/EP0866711B1/de not_active Expired - Lifetime
- 1996-10-24 JP JP9516832A patent/JPH11515015A/ja not_active Ceased
- 1996-10-24 WO PCT/US1996/017184 patent/WO1997015309A1/en not_active Ceased
- 1996-10-24 PT PT96936996T patent/PT866711E/pt unknown
- 1996-10-24 DK DK96936996T patent/DK0866711T3/da active
- 1996-10-24 US US09/051,859 patent/US5968932A/en not_active Expired - Fee Related
- 1996-10-24 AT AT96936996T patent/ATE333880T1/de not_active IP Right Cessation

Also Published As

Publication number	Publication date
AU714270B2 (en)	1999-12-23
EP0866711A1 (de)	1998-09-30
JPH11515015A (ja)	1999-12-21
ES2268712T3 (es)	2007-03-16
DE69636393D1 (de)	2006-09-07
HK1015283A1 (en)	1999-10-15
AU7477096A (en)	1997-05-15
EP0866711A4 (de)	2003-04-16
EP0866711B1 (de)	2006-07-26
CA2235854A1 (en)	1997-05-01
US5968932A (en)	1999-10-19
WO1997015309A1 (en)	1997-05-01
DK0866711T3 (da)	2006-11-27
DE69636393T2 (de)	2006-12-07
PT866711E (pt)	2006-12-29

Similar Documents

Publication	Publication Date	Title
FI954609A0 (fi)	1995-09-28	1-amidinofenyyli-pyrrolidoneja, -piperidinoneja ja -atsetinoneja verihiutaleiden kasaantumisen inhibiittoreina
DE69417733D1 (de)	1999-05-12	Verfahren zur hemmung des knochenschwundes mit 3,4-diarylchroman
DE69616333D1 (de)	2001-11-29	Thip zur behandlung von schlafstörungen
DE69635459D1 (de)	2005-12-22	Acetylcholinesteraseinhibitoren zur behandlung und diagnose von atemstörungen während des schlafes
DE69727956D1 (de)	2004-04-08	Pharmazeutische zubereitungen zur verminderung von atmungsdepressionen
ATE189601T1 (de)	2000-02-15	Verwendung von raloxifen und dessen analogen zur herstellung eines medikaments zur behandlung viraler erkrankungen
DE59401401D1 (de)	1997-02-06	Pharmazeutische formulierung zur behandlung der nicotinabhängigkeit
GB9317636D0 (en)	1993-10-13	Use of dexmedetomidine
DE69636393D1 (de)	2006-09-07	Montirelin zur verhinderung der schlafapnoe
DE69612510D1 (de)	2001-05-17	Verwendung von 1-(2-naphtylethyl)-4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridin zur herstellung eines medikaments zur behandlung der amyotrophen lateralsklerode
DE69706382D1 (de)	2001-10-04	Verfahren zur herstellung von 2,2'-bipyrrolyl-pyrromethen-derivaten (prodigiosine)
FI934680A0 (fi)	1993-10-22	Arylmorfolin, framstaellning och anvaending
MY114428A (en)	2002-10-31	New pharmacological use of aii-receptor antagonists
EA199700136A1 (ru)	1997-12-30	Способы ингибирования экзогенных эстрогенов
IL108288A0 (en)	1994-04-12	Pyrrolidine derivatives, their preparation and medicaments containing them
MXPA04003631A (es)	2004-07-30	Rosuvastatina en estados de pre-demencia.
ATE240101T1 (de)	2003-05-15	Verwendung von 2-phenyl-3- aroylbenzothiophenderivaten zur herstellung eines medikaments zur knochen- und bruchheilung
ES2137665T3 (es)	1999-12-16	Nuevos derivados de piridina o piridazina, procedimientos para su preparacion, y medicamentos que contienen estos compuestos.
IL108841A0 (en)	1994-06-24	Benzopyrans
ATE254919T1 (de)	2003-12-15	Verwendung von penciclovir zur behandlung von menschlichem herpes virus-8
ATE179890T1 (de)	1999-05-15	Verwendung von benzothiophenen zur herstellung eines medikaments zur verminderung der narbenbildung bei der wundheilung
DE69832796D1 (de)	2006-01-19	Verwendung von mizolastine zur herstellung eines arzneimittels zur behandlung von entzündungen
HU9502062D0 (en)	1995-09-28	Application of riluzole as a radiorestorer
DE69429538D1 (de)	2002-01-31	Verwendung von 2-aminopurinderivaten zur behandlung und prophylaxe der menschlichen herpesvirus 6 infektionen
MX9701528A (es)	1998-06-28	Derivados de 1, 1, 2,- trifenilbut-1-eno para tratar la enfermedad de alzheimer.

Legal Events

Date

Code

Title

Description

2007-04-15

UEP

Publication of translation of european patent specification

Ref document number: 0866711

Country of ref document: EP

2008-07-15

REN

Ceased due to non-payment of the annual fee